Literature DB >> 8560978

Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain.

K Jendroska1, W Poewe, S E Daniel, J Pluess, H Iwerssen-Schmidt, J Paulsen, S Barthel, L Schelosky, J Cervós-Navarro, S J DeArmond.   

Abstract

The histoblot immunostaining technique for locating and characterizing amyloidogenic proteins was used to obtain information about the relationship of cerebral ischemia/hypoxia to the accumulation of amyloid beta protein (A beta). We investigated brains of 131 subjects (ages 25-94 years, mean 72 years). Three distribution patterns of A beta immunoreactivity were identified: (1) colocalization with diffuse and neuritic plaques of Alzheimer's disease (AD) and aging; (2) diffuse punctuate deposits in the cerebral cortex in association with small vessel cerebral vascular disease ; and (3) cerebral cortical accumulation localized to arterial boundary zones and other regions susceptible to ischemic/hypoxic injury designated "stress-induced deposits" (SID). SID were not identified in tissue sections by immunohistochemical, Congo red or Bielschowsky silver techniques; no histological abnormalities were present in adjacent formalin-fixed tissue sections, SID occurred in subjects with histories of cerebral ischemia, and severe orthostatic hypotension. There was also an association with aging in general and with the incidence of neuritic plaques specifically. These latter findings are consistent with the hypothesis that brain ischemia/hypoxia plays a role in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560978     DOI: 10.1007/bf00294806

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  22 in total

1.  Cerebral perfusion as a diagnostic marker of early Alzheimer's disease.

Authors:  I Prohovnik; R Mayeux; H A Sackeim; G Smith; Y Stern; P O Alderson
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

2.  Observations on the brains of demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1970-09       Impact factor: 3.181

3.  [The vascular factor in the pathogenesis of acute necrotizing encephalitis].

Authors:  J Escalona Zapata; J Cervós-Navarro
Journal:  Dtsch Z Nervenheilkd       Date:  1969

4.  Temporal profiles of accumulation of amyloid beta/A4 protein precursor in the gerbil after graded ischemic stress.

Authors:  H Tomimoto; H Wakita; I Akiguchi; S Nakamura; J Kimura
Journal:  J Cereb Blood Flow Metab       Date:  1994-07       Impact factor: 6.200

5.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

6.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

Authors:  R S Frackowiak; C Pozzilli; N J Legg; G H Du Boulay; J Marshall; G L Lenzi; T Jones
Journal:  Brain       Date:  1981-12       Impact factor: 13.501

7.  A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

Authors:  L Davies; B Wolska; C Hilbich; G Multhaup; R Martins; G Simms; K Beyreuther; C L Masters
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

8.  Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease.

Authors:  E Cochran; B Bacci; Y Chen; A Patton; P Gambetti; L Autilio-Gambetti
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

9.  Increased levels of the Kunitz protease inhibitor-containing beta APP mRNAs in rat brain following neurotoxic damage.

Authors:  C Solà; F J García-Ladona; G Mengod; A Probst; P Frey; J M Palacios
Journal:  Brain Res Mol Brain Res       Date:  1993-01

10.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

View more
  46 in total

Review 1.  The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.

Authors:  Costantino Iadecola
Journal:  Acta Neuropathol       Date:  2010-07-11       Impact factor: 17.088

Review 2.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

3.  PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.

Authors:  Gehua Zhen; Yun Tai Kim; Rung-chi Li; Jennifer Yocum; Nidhi Kapoor; John Langer; Peter Dobrowolski; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurobiol Aging       Date:  2011-10-19       Impact factor: 4.673

4.  Clearance of amyloid-β protein deposits in transgenic mice following focal cerebral ischemia.

Authors:  W E Van Nostrand; J Davis; M L Previti; F Xu
Journal:  Neurodegener Dis       Date:  2012-01-21       Impact factor: 2.977

5.  Orthostatic hypotension and attention in Parkinson's disease with and without dementia.

Authors:  C Peralta; M Stampfer-Kountchev; E Karner; M Köllensperger; F Geser; E Wolf; K Seppi; T Benke; W Poewe; G K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2007-01-03       Impact factor: 3.575

6.  Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.

Authors:  Jens Göttler; Christine Preibisch; Isabelle Riederer; Lorenzo Pasquini; Panagiotis Alexopoulos; Karl Peter Bohn; Igor Yakushev; Ebba Beller; Stephan Kaczmarz; Claus Zimmer; Timo Grimmer; Alexander Drzezga; Christian Sorg
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-12       Impact factor: 6.200

7.  Alteration of phosphoinositide degradation by cytosolic and membrane-bound phospholipases after forebrain ischemia-reperfusion in gerbil: effects of amyloid beta peptide.

Authors:  J Strosznajder; A Zambrzycka; M D Kacprzak; D Kopczuk; R P Strosznajder
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

Review 8.  Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease.

Authors:  Dennis W Dickson
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

9.  Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes.

Authors:  Thomas Tousseyn; Krystyna Bajsarowicz; Henry Sánchez; Ania Gheyara; Abby Oehler; Michael Geschwind; Bernadette DeArmond; Stephen J DeArmond
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

10.  Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Marzena U Amek
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.